Artios Pharma
PrivateLast Round
Series D
11/17/2025
Total Funding Raised
$385.2M
Momentum Score
25 /100
Company Overview
Artios Pharma is a biotechnology company developing a pipeline of cancer treatments that target the DNA Damage Response (DDR) process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artios Pharma Comps
Public and private peers based on sector, stage, and business model.
Artios Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 11/17/2025 | ||||
| Series C | 7/27/2021 | ||||
| Series B | 8/10/2018 | ||||
| Series A | 9/21/2016 |
Artios Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Janus Henderson Group | Series D |
| RA Capital Management | Series D |
| TCG Crossover | Series C |
| Omega Funds | Series D, Series C |
| EQT Life Sciences | Series D, Series B |
| SV Health Investors | Series B, Series C, Series A, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 16, 2026
Roy W. Ware joins to lead CMSC operations for therapeutics pipeline.
- Jan 7, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
Artios Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artios Pharma's valuation, stock price, and market status.
